Development of Breast Cancer Spheroids to Evaluate Cytotoxic Response to an Anticancer Peptide
Breast cancer (BC) is the most commonly diagnosed cancer in women and one of the most common causes of cancer-related deaths. Despite intense research efforts, BC treatment still remains challenging. Improved drug development strategies are needed for impactful benefit to patients. Current preclinic...
Enregistré dans:
Auteurs principaux: | Marco Cavaco, Patrícia Fraga, Javier Valle, David Andreu, Miguel A. R. B. Castanho, Vera Neves |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f01c0e8ba06d4b4390251fcc52ee3d03 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Integrative Bioinformatics Analysis Reveals Possible Target and Mechanism of Ellipticine Against Breast Cancer Stem Cells.
par: Adam Hermawan, et autres
Publié: (2021) -
Exploration of Benzenesulfonamide-Bearing Imidazole Derivatives Activity in Triple-Negative Breast Cancer and Melanoma 2D and 3D Cell Cultures
par: Benas Balandis, et autres
Publié: (2021) -
Natural Bioactive Cyclopeptides from Microbes as Promising Anticancer Drug Leads: A Mini-review
par: Linda Sukmarini
Publié: (2021) -
Some novel hybrid quinazoline-based heterocycles as potent cytotoxic agents
par: Mahla Malekzadeh, et autres
Publié: (2022) -
Multicellular Ovarian Cancer Model for Evaluation of Nanovector Delivery in Ascites and Metastatic Environments
par: Stephen J. Winter, et autres
Publié: (2021)